Last reviewed · How we verify
NCT06380062
Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia
trial testing Plasma concentration of choline in Primary Prostate Urothelial Cancer in 350 participants. Completed in 30 November 2015.
30 November 2015
Quick facts
| Lead sponsor | Universität des Saarlandes |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 12 January 2012 |
| Primary completion | 30 November 2015 |
| Estimated completion | 30 November 2015 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Plasma concentration of choline
Conditions studied
- Primary Prostate Urothelial Cancer — all drugs for Primary Prostate Urothelial Cancer →
- Benign Prostatic Hyperplasia — all drugs for Benign Prostatic Hyperplasia →
Sponsor
Universität des Saarlandes — full company profile →
Who can join
50 and older, male only, with Primary Prostate Urothelial Cancer or Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to investigate plasma concentrations of one-carbon metabolites and phospholipid classes in participants with primary prostate cancer and those with benign hyperplasia. Moreover, the metabolites were studied in relation to tumor grade and age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06380062
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universität des Saarlandes trials
Trials by the same sponsor.
- NCT07530809 — Time-restricted Feeding in MASLD · NA · recruiting
- NCT06865950 — Sex diffErences in prehoSpitAl Stroke MEdicine · recruiting
- NCT06907563 — Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study) · not yet recruiting
- NCT06453577 — Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure · active not recruiting
- NCT06459115 — Adherence to Medication in Patients With Acute Decompensated Heart Failure · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06380062 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universität des Saarlandes
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06380062.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing